Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001746473-25-000054
Filing Date
2025-03-03
Accepted
2025-03-03 16:10:46
Documents
110
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K plrx-20241231.htm   iXBRL 10-K 1815108
2 EX-10.14 INDUCEMENT PLAN exhibit10142022inducementp.htm EX-10.14 8286
3 EX-10.19 NON-EMPLOYEE DIRECTOR COMPENSATION exhibit1019non-employeedir.htm EX-10.19 22338
4 EX-19.1 INSIDER TRADING COMPLIANCE POLICY exhibit191insidertradingco.htm EX-19.1 111033
5 EX-23.1 AUDITOR CONSENT exhibit231auditorsconsent.htm EX-23.1 2413
6 EX-31.1 CEO CERTIFICATION exhibit311ceocertification.htm EX-31.1 10261
7 EX-31.2 CFO CERTIFICATION exhibit312cfocertification.htm EX-31.2 9819
8 EX-32.1 CEO AND CFO CERTIFICATION exhibit321ceoandcfocertifi.htm EX-32.1 5933
14 plrx-20241231_g1.jpg GRAPHIC 129150
15 plrx-20241231_g2.jpg GRAPHIC 40953
  Complete submission text file 0001746473-25-000054.txt   9573209

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20241231.xsd EX-101.SCH 68461
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20241231_cal.xml EX-101.CAL 77639
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20241231_def.xml EX-101.DEF 307725
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20241231_lab.xml EX-101.LAB 790485
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20241231_pre.xml EX-101.PRE 578659
113 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20241231_htm.xml XML 1075403
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39303 | Film No.: 25697987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)